Inventor · disambiguated record
Frédéric Marc Maurice Doublet
Also filed as: DOUBLET FREDERIC M M · DOUBLET FREDERIC MARC MAURICE · DOUBLET FRÉDÉRIC MARC MAURICE
17 granted patents·3 pending applications·44 citations·filing 2004–2021
90Inventor score
Files withBONFANTI JEAN-FRANCOIS6JANSSEN SCIENCES IRELAND UNLIMITED CO5JANSSEN R & D IRELAND3JANSSEN SCIENCES IRELAND UC3TIBOTEC PHARM LTD3
Top patents by PatentIndex Score
20 records- 0195US9556176B2Purine derivatives for the treatment of viral infectionsJANSSEN R&D IRELAND·Filed 2012·Granted Jan 31, 2017·29 cites·4 claims
- 0282US10266543B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2014·Granted Apr 23, 2019·2 cites·20 claims
- 0376US10280167B2Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted May 7, 2019·1 cites·4 claims
- 0476US8034835B21-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogsTIBOTEC PHARM LTD·Filed 2006·Granted Oct 11, 2011·3 cites·13 claims
- 0573US9725432B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2013·Granted Aug 8, 2017·2 cites·4 claims
- 0673US2022235052A1Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 0772US7449463B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Nov 11, 2008·6 cites·36 claims
- 0870US11702426B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 0970US11104678B2Purine derivatives for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Aug 31, 2021·0 cites·12 claims
- 1070US10280180B2Macrocyclic purines for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted May 7, 2019·1 cites·8 claims
- 1168US10829494B2Macrocyclic deaza-purinones for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Nov 10, 2020·0 cites·17 claims
- 1265US10822349B2Macrocyclic purines for the treatment of viral infectionsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Nov 3, 2020·0 cites·9 claims
- 1354US8278455B25- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Oct 2, 2012·0 cites·12 claims
- 1453US8883837B2Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2008·Granted Nov 11, 2014·0 cites·28 claims
- 1549US2007093502A15- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replicationBONFANTI JEAN-FRANCOIS·Filed 2004·Application pending·0 cites
- 1648US10221157B2Pyrimidine derivatives for the treatment of bacterial diseasesJANSSEN R&D IRELAND·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 1743US8044073B2Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replicationTIBOTEC PHARM LTD·Filed 2004·Granted Oct 25, 2011·0 cites·29 claims
- 1842US8178694B2Heterocyclylaminoalkyl substituted benzimidazolesBONFANTI JEAN-FRANCOIS·Filed 2006·Granted May 15, 2012·0 cites·15 claims
- 1942US7884215B22-substituted benzimidazolesBONFANTI JEAN-FRANCOIS·Filed 2006·Granted Feb 8, 2011·0 cites·10 claims
- 2042US2009221559A1Benzodiazepines as hcv inhibitorsBONFANTI JEAN-FRANCOIS·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →